{"count": 53, "results": [{"_id": "40033492", "pmid": 40033492, "title": "EXPRESS: Metformin; Its Salutary Effects Beyond Diabetes Mellitus.", "journal": "J Investig Med", "authors": ["Sawalha K", "Gautam N", "Sivakumar K", "Paydak H", "Mehta J"], "date": "2025-03-03T00:00:00Z", "doi": "10.1177/10815589251327511", "meta_date_publication": "2025 Mar 3", "meta_volume": "", "meta_issue": "", "meta_pages": "10815589251327511", "score": 50260.008, "text_hl": "The goal of this review is to assess the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ (@<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@), but more importantly its effects on disease states other than @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@.", "citations": {"NLM": "Sawalha K, Gautam N, Sivakumar K, Paydak H, Mehta J. EXPRESS: Metformin; Its Salutary Effects Beyond Diabetes Mellitus. J Investig Med. 2025 Mar 3;():10815589251327511. PMID: 40033492", "BibTeX": "@article{40033492, title={EXPRESS: Metformin; Its Salutary Effects Beyond Diabetes Mellitus.}, author={Sawalha K and Gautam N and Sivakumar K and Paydak H and Mehta J}, journal={J Investig Med}, pages={10815589251327511}}"}}, {"_id": "36254086", "pmid": 36254086, "pmcid": "PMC9575712", "title": "Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients", "journal": "Medicine (Baltimore)", "authors": ["Chen M", "Ma F", "Su B", "Wang C", "Zheng Q", "Zhang Y", "Li M", "Liu S", "Zhang S", "Yuan L"], "date": "2022-10-14T00:00:00Z", "doi": "10.1097/MD.0000000000031107", "meta_date_publication": "2022 Oct 14", "meta_volume": "101", "meta_issue": "41", "meta_pages": "e31107", "score": 50258.477, "text_hl": "Treatment effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combined with @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ in reducing in-stent @DISEASE_Coronary_Restenosis @DISEASE_MESH:D023903 @@@restenosis@@@ after percutaneous coronary intervention in @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetic@@@ patients", "citations": {"NLM": "Chen M, Ma F, Su B, Wang C, Zheng Q, Zhang Y, Li M, Liu S, Zhang S, Yuan L. Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients Medicine (Baltimore). 2022 Oct 14;101(41):e31107. PMID: 36254086", "BibTeX": "@article{36254086, title={Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients}, author={Chen M and Ma F and Su B and Wang C and Zheng Q and Zhang Y and Li M and Liu S and Zhang S and Yuan L}, journal={Medicine (Baltimore)}, volume={101}, number={41}, pages={e31107}}"}}, {"_id": "37554894", "pmid": 37554894, "pmcid": "PMC10405991", "title": "Serum lipoprotein(a), and plasminogen activator inhibitor-1 in uncomplicated type 2 diabetes mellitus: a case-control study", "journal": "Ann Med Surg (Lond)", "authors": ["Abdullah FE", "Ahmed SN"], "date": "2023-07-03T00:00:00Z", "doi": "10.1097/MS9.0000000000000915", "meta_date_publication": "2023 Aug", "meta_volume": "85", "meta_issue": "8", "meta_pages": "3801-3805", "score": 50256.754, "text_hl": "Early investigations with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ showed an increase in overall fibrinolytic activity in those with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, @DISEASE_Peripheral_Vascular_Diseases @DISEASE_MESH:D016491 @@@peripheral vascular disease@@@, and @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@. ", "citations": {"NLM": "Abdullah FE, Ahmed SN. Serum lipoprotein(a), and plasminogen activator inhibitor-1 in uncomplicated type 2 diabetes mellitus: a case-control study Ann Med Surg (Lond). 2023 Aug;85(8):3801-3805. PMID: 37554894", "BibTeX": "@article{37554894, title={Serum lipoprotein(a), and plasminogen activator inhibitor-1 in uncomplicated type 2 diabetes mellitus: a case-control study}, author={Abdullah FE and Ahmed SN}, journal={Ann Med Surg (Lond)}, volume={85}, number={8}, pages={3801-3805}}"}}, {"_id": "35282660", "pmid": 35282660, "title": "Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis.", "journal": "Cardiovasc Diagn Ther", "authors": ["Kataoka Y", "Nicholls SJ", "Andrews J", "Uno K", "Kapadia SR", "Tuzcu EM", "Nissen SE", "Puri R"], "date": "2022-02-01T00:00:00Z", "doi": "10.21037/cdt-21-346", "meta_date_publication": "2022 Feb", "meta_volume": "12", "meta_issue": "1", "meta_pages": "77-87", "score": 50252.527, "text_hl": "Plaque microstructures during @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetic@@@ subjects with @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@: optical coherence tomography analysis.", "citations": {"NLM": "Kataoka Y, Nicholls SJ, Andrews J, Uno K, Kapadia SR, Tuzcu EM, Nissen SE, Puri R. Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis. Cardiovasc Diagn Ther. 2022 Feb;12(1):77-87. PMID: 35282660", "BibTeX": "@article{35282660, title={Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis.}, author={Kataoka Y and Nicholls SJ and Andrews J and Uno K and Kapadia SR and Tuzcu EM and Nissen SE and Puri R}, journal={Cardiovasc Diagn Ther}, volume={12}, number={1}, pages={77-87}}"}}, {"_id": "40475712", "pmid": 40475712, "title": "Long-term Metformin Alters Gut Microbiota and Serum Metabolome in Coronary Artery Disease Patients After Percutaneous Coronary Intervention to Improve 5-year Prognoses: A Multi-omics Analysis.", "journal": "Rev Cardiovasc Med", "authors": ["Zhou R", "Wu Q", "Qian H", "Wang L", "Liu G", "Zhang B", "Wu W", "Zhang S"], "date": "2025-05-27T00:00:00Z", "doi": "10.31083/RCM26835", "meta_date_publication": "2025 May", "meta_volume": "26", "meta_issue": "5", "meta_pages": "26835", "score": 50250.477, "text_hl": "Long-term @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Alters Gut Microbiota and Serum Metabolome in @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@Coronary Artery Disease@@@ @SPECIES_9606 @@@Patients@@@ After Percutaneous Coronary Intervention to Improve 5-year Prognoses: A Multi-omics Analysis.", "citations": {"NLM": "Zhou R, Wu Q, Qian H, Wang L, Liu G, Zhang B, Wu W, Zhang S. Long-term Metformin Alters Gut Microbiota and Serum Metabolome in Coronary Artery Disease Patients After Percutaneous Coronary Intervention to Improve 5-year Prognoses: A Multi-omics Analysis. Rev Cardiovasc Med. 2025 May;26(5):26835. PMID: 40475712", "BibTeX": "@article{40475712, title={Long-term Metformin Alters Gut Microbiota and Serum Metabolome in Coronary Artery Disease Patients After Percutaneous Coronary Intervention to Improve 5-year Prognoses: A Multi-omics Analysis.}, author={Zhou R and Wu Q and Qian H and Wang L and Liu G and Zhang B and Wu W and Zhang S}, journal={Rev Cardiovasc Med}, volume={26}, number={5}, pages={26835}}"}}, {"_id": "37239987", "pmid": 37239987, "pmcid": "PMC10218481", "title": "Overexpression of microRNA-21-5p and microRNA-221-5p in Monocytes Increases the Risk of Developing Coronary Artery Disease", "journal": "Int J Mol Sci", "authors": ["Torres-Paz YE", "Gamboa R", "Fuentevilla-Álvarez G", "Soto ME", "González-Moyotl N", "Martínez-Alvarado R", "Torres-Tamayo M", "Ramírez-Marroquín ES", "Vásquez-Jiménez X", "Sainz-Escarrega V", "Huesca-Gómez C"], "date": "2023-05-12T00:00:00Z", "doi": "10.3390/ijms24108641", "meta_date_publication": "2023 May 12", "meta_volume": "24", "meta_issue": "10", "meta_pages": "", "score": 50250.223, "text_hl": "The data are expressed as median (min-max). p1 = @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ unmedicated group with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ vs. healthy controls, p2 = @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ medicated group with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ vs. control, p = 3 @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ unmedicated group with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D0086", "citations": {"NLM": "Torres-Paz YE, Gamboa R, Fuentevilla-Álvarez G, Soto ME, González-Moyotl N, Martínez-Alvarado R, Torres-Tamayo M, Ramírez-Marroquín ES, Vásquez-Jiménez X, Sainz-Escarrega V, Huesca-Gómez C. Overexpression of microRNA-21-5p and microRNA-221-5p in Monocytes Increases the Risk of Developing Coronary Artery Disease Int J Mol Sci. 2023 May 12;24(10):. PMID: 37239987", "BibTeX": "@article{37239987, title={Overexpression of microRNA-21-5p and microRNA-221-5p in Monocytes Increases the Risk of Developing Coronary Artery Disease}, author={Torres-Paz YE and Gamboa R and Fuentevilla-Álvarez G and Soto ME and González-Moyotl N and Martínez-Alvarado R and Torres-Tamayo M and Ramírez-Marroquín ES and Vásquez-Jiménez X and Sainz-Escarrega V and Huesca-Gómez C}, journal={Int J Mol Sci}, volume={24}, number={10}}"}}, {"_id": "31636172", "pmid": 31636172, "pmcid": "PMC6925585", "title": "Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors", "journal": "Diabetes", "authors": ["Merino J", "Jablonski KA", "Mercader JM", "Kahn SE", "Chen L", "Harden M", "Delahanty LM", "Araneta MRG", "Walford GA", "Jacobs SBR", "Ibebuogu UN", "Franks PW", "Knowler WC", "Florez JC", "Diabetes Prevention Program Research Group"], "date": "2020-01-01T00:00:00Z", "doi": "10.2337/db19-0097", "meta_date_publication": "2020 Jan", "meta_volume": "69", "meta_issue": "1", "meta_pages": "112-120", "score": 50247.098, "text_hl": "Participants in both the lifestyle and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ interventions had greater improvement in the majority of recognized CRFs compared with placebo (P < 0.001) irrespective of @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ genetic risk (Pinteraction > 0.05). ", "citations": {"NLM": "Merino J, Jablonski KA, Mercader JM, Kahn SE, Chen L, Harden M, Delahanty LM, Araneta MRG, Walford GA, Jacobs SBR, Ibebuogu UN, Franks PW, Knowler WC, Florez JC, Diabetes Prevention Program Research Group. Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors Diabetes. 2020 Jan;69(1):112-120. PMID: 31636172", "BibTeX": "@article{31636172, title={Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors}, author={Merino J and Jablonski KA and Mercader JM and Kahn SE and Chen L and Harden M and Delahanty LM and Araneta MRG and Walford GA and Jacobs SBR and Ibebuogu UN and Franks PW and Knowler WC and Florez JC and Diabetes Prevention Program Research Group}, journal={Diabetes}, volume={69}, number={1}, pages={112-120}}"}}, {"_id": "37734206", "pmid": 37734206, "pmcid": "PMC10514430", "title": "Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study", "journal": "EBioMedicine", "authors": ["Zheng J", "Xu M", "Yang Q", "Hu C", "Walker V", "Lu J", "Wang J", "Liu R", "Xu Y", "Wang T", "Zhao Z", "Yuan J", "Burgess S", "Au Yeung SL", "Luo S", "Anderson EL", "Holmes MV", "Smith GD", "Ning G", "Wang W", "Gaunt TR", "Bi Y"], "date": "2023-09-19T00:00:00Z", "doi": "10.1016/j.ebiom.2023.104803", "meta_date_publication": "2023 Sep 19", "meta_volume": "96", "meta_issue": "", "meta_pages": "104803", "score": 50246.32, "text_hl": "S3 presents the target-specific results of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ targets on @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@, BMI, SBP and DBP. ", "citations": {"NLM": "Zheng J, Xu M, Yang Q, Hu C, Walker V, Lu J, Wang J, Liu R, Xu Y, Wang T, Zhao Z, Yuan J, Burgess S, Au Yeung SL, Luo S, Anderson EL, Holmes MV, Smith GD, Ning G, Wang W, Gaunt TR, Bi Y. Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study EBioMedicine. 2023 Sep 19;96():104803. PMID: 37734206", "BibTeX": "@article{37734206, title={Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study}, author={Zheng J and Xu M and Yang Q and Hu C and Walker V and Lu J and Wang J and Liu R and Xu Y and Wang T and Zhao Z and Yuan J and Burgess S and Au Yeung SL and Luo S and Anderson EL and Holmes MV and Smith GD and Ning G and Wang W and Gaunt TR and Bi Y}, journal={EBioMedicine}, volume={96}, pages={104803}}"}}, {"_id": "33002553", "pmid": 33002553, "title": "Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease.", "journal": "Diabetes Res Clin Pract", "authors": ["Werida R", "Kabel M", "Omran G", "Shokry A", "Mostafa T"], "date": "2020-12-01T00:00:00Z", "doi": "10.1016/j.diabres.2020.108473", "meta_date_publication": "2020 Dec", "meta_volume": "170", "meta_issue": "", "meta_pages": "108473", "score": 50246.06, "text_hl": "Comparative clinical study evaluating the effect of adding @CHEMICAL_Vildagliptin @CHEMICAL_MESH:D000077597 @@@Vildagliptin@@@ versus @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@Glimepiride@@@ to ongoing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ therapy on @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with symptomatic @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@.", "citations": {"NLM": "Werida R, Kabel M, Omran G, Shokry A, Mostafa T. Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease. Diabetes Res Clin Pract. 2020 Dec;170():108473. PMID: 33002553", "BibTeX": "@article{33002553, title={Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease.}, author={Werida R and Kabel M and Omran G and Shokry A and Mostafa T}, journal={Diabetes Res Clin Pract}, volume={170}, pages={108473}}"}}, {"_id": "39201292", "pmid": 39201292, "title": "Involvement of Expression of miR33-5p and ABCA1 in Human Peripheral Blood Mononuclear Cells in Coronary Artery Disease.", "journal": "Int J Mol Sci", "authors": ["Torres-Paz YE", "Gamboa R", "Fuentevilla-Álvarez G", "Cardoso-Saldaña G", "Martínez-Alvarado R", "Soto ME", "Huesca-Gómez C"], "date": "2024-08-07T00:00:00Z", "doi": "10.3390/ijms25168605", "meta_date_publication": "2024 Aug 7", "meta_volume": "25", "meta_issue": "16", "meta_pages": "", "score": 50243.406, "text_hl": "Downregulation of miR-33a-5p and upregulation of @GENE_ABCA1 @GENE_19 @@@ABCA1@@@ were linked to a lower @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ risk. @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@Atorvastatin@@@ upregulated @GENE_ABCA1 @GENE_19 @@@ABCA1@@@ mRNA, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ downregulated miR-26a-5p in @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Torres-Paz YE, Gamboa R, Fuentevilla-Álvarez G, Cardoso-Saldaña G, Martínez-Alvarado R, Soto ME, Huesca-Gómez C. Involvement of Expression of miR33-5p and ABCA1 in Human Peripheral Blood Mononuclear Cells in Coronary Artery Disease. Int J Mol Sci. 2024 Aug 7;25(16):. PMID: 39201292", "BibTeX": "@article{39201292, title={Involvement of Expression of miR33-5p and ABCA1 in Human Peripheral Blood Mononuclear Cells in Coronary Artery Disease.}, author={Torres-Paz YE and Gamboa R and Fuentevilla-Álvarez G and Cardoso-Saldaña G and Martínez-Alvarado R and Soto ME and Huesca-Gómez C}, journal={Int J Mol Sci}, volume={25}, number={16}}"}}]}